- The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals' cannabidiol as an adjunctive treatment of seizures associated with tuberous sclerosis complex (TSC) for patients two years of age and older.
- GW is a part of Jazz Pharmaceuticals plc JAZZ. Epidiolex/Epidyolex (cannabidiol) is a prescription, plant-derived cannabis-based medicine.
- Concurrently, Jazz and Stand Up To Cancer (SU2C) have announced a three-year, $4 million research collaboration to explore new opportunities, including lurbinectedin in pediatric solid tumors and pan-RAF molecules in RAF- and RAS-mutated solid cancers.
- The collaboration between the companies will provide SU2C-funded researchers access to two Jazz molecules and funds to support one or more research projects over three years.
- The collaboration may also support non-clinical studies of an investigational pan-RAF inhibitor compound called JZP815 in RAF- and RAS-mutated solid cancers.
- Price Action: JAZZ shares are up 2.4% at $147.36 during the market session on the last check Tuesday.
- Related content: Benzinga's Full FDA Calendar.
- Photo by Rex Medlen from Pixabay
JAZZJazz Pharmaceuticals PLC
$99.75-2.25%
Edge Rankings
Momentum
50.37
Growth
-
Quality
68.12
Value
33.60
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!